Risperidone and perphenazine in the treatment of senile schizophrenia.doc

Risperidone and perphenazine in the treatment of senile schizophrenia.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Risperidone and perphenazine in the treatment of senile schizophrenia

 PAGE \* MERGEFORMAT 7 Risperidone and perphenazine in the treatment of senile schizophrenia Of: Luai Yi, Cao Yongkang, Pan Yu Biao [Abstract] Objective To compare risperidone and perphenazine for schizophrenia and old age security. Methods 68 elderly patients with schizophrenia were randomly divided into two groups, respectively, risperidone or perphenazine treatment of 8 weeks, both groups before and after treatment in the treatment of 2,4,8 weekend with the Positive and Negative Syndrome Scale (PANSS and adverse Symptom Scale (TESS [1] assessed the efficacy and adverse reactions. Results efficient risperidone group 82.4%, perphenazine group was 76.5%, the two groups showed no significant clinical differences (Pgt; 0.05, risperidone group 8 weeks after treatment of negative symptoms sub-group was significantly lower than perphenazine, perphenazine group than in less adverse reactions and light. Conclusion risperidone and perphenazine in the treatment of senile schizophrenia clinical efficacy equivalent, but the negative symptoms of risperidone treatment on efficacy and safety superior to perphenazine. [Keywords:] risperidone in schizophrenia in old age perphenazine New atypical antipsychotic drugs on positive and negative symptoms are a therapeutic effect, and adverse drug reaction, in the treatment of mental illness more and more attention. In this paper, perphenazine as a control to compare risperidone in elderly of the efficacy and safety of schizophrenia, are as follows. Subjects and Methods 1. Objects All patients from our hospital in January 2007 to 12 months of outpatient or hospitalized patients, are in line with the Chinese Classification and Diagnostic Criteria of Mental Disorders Version 3 (CCMD 3 diagnostic criteria of schizophrenia, agegt; = 60 years old, male or female , 1 week before enrollment did not use antipsychotic medication, PANSS total scoregt; = 60 points, excluding a serious physical illness, alcohol or drug abuse

文档评论(0)

hhuiws1482 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档